AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin

Abstract The ternary combination like omeprazole (OMP), amoxicillin (AMX), and rifabutin (RFB) was approved by the FDA in November 2019 for combating Helicobacter pylori infections and ulcers caused by this infection. This study aims to develop and authenticate a robust and eco-friendly RP-UPLC tech...

Full description

Saved in:
Bibliographic Details
Main Authors: S. P. Ashnah Baffinsha, Vijayageetha Ragupathi, Hemanth Kumar Chanduluru
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Chemistry
Subjects:
Online Access:https://doi.org/10.1186/s13065-024-01337-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158789436243968
author S. P. Ashnah Baffinsha
Vijayageetha Ragupathi
Hemanth Kumar Chanduluru
author_facet S. P. Ashnah Baffinsha
Vijayageetha Ragupathi
Hemanth Kumar Chanduluru
author_sort S. P. Ashnah Baffinsha
collection DOAJ
description Abstract The ternary combination like omeprazole (OMP), amoxicillin (AMX), and rifabutin (RFB) was approved by the FDA in November 2019 for combating Helicobacter pylori infections and ulcers caused by this infection. This study aims to develop and authenticate a robust and eco-friendly RP-UPLC technique aimed at the concurrent analysis of OMP, AMX, and RFB, following ICH guidelines, Analytical Quality by Design (AQbD), and green analytical chemistry (GAC) principles. The analysis used the Thermo C18 column (100 mm × 2.1 mm, 1.7 µm), ethanol, and formic acid solution (43:57) as mobile phase with a flow rate of 0.2 ml/min at 272 nm. The method was developed based on the ICH Q14 and validated according to ICH Q2(R1) followed by Forced degradation studies under various conditions. The method showed good linearity for OMP, AMX, and RFB, with coefficient of determination (r2) of 0.9995, 0.9993, and 0.9997, respectively. Precision studies indicated low %RSD values, confirming high reproducibility. Forced degradation studies confirmed the stability of the drugs for 30 min in acid, base, and redox reactions, and they were also stable for 6 h at 105 °C in dry conditions. GAPI assessment depicted a green and yellow pictogram, AGREE scored 0.85, BAGI scored 80, and RGB12 Whiteness Assessment Tool scored 97.5%. The developed RP-UPLC-PDA technique is robust and reliable for the concurrent quantification of the triple combination. It aligns with sustainability goals, enhancing the efficiency and environmental sustainability of pharmaceutical analysis, and setting a benchmark for future analytical methods.
format Article
id doaj-art-11d2da9e8431469e82bc622215d4ccd3
institution Kabale University
issn 2661-801X
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Chemistry
spelling doaj-art-11d2da9e8431469e82bc622215d4ccd32024-11-24T12:09:14ZengBMCBMC Chemistry2661-801X2024-11-0118111810.1186/s13065-024-01337-6AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutinS. P. Ashnah Baffinsha0Vijayageetha Ragupathi1Hemanth Kumar Chanduluru2Department of Pharmaceutical Analysis, C.L Baid Metha College of PharmacyDepartment of Pharmaceutical Analysis, C.L Baid Metha College of PharmacyDepartment of Pharmaceutical Research, SRM College of Pharmacy, SRM Institute of Science and TechnologyAbstract The ternary combination like omeprazole (OMP), amoxicillin (AMX), and rifabutin (RFB) was approved by the FDA in November 2019 for combating Helicobacter pylori infections and ulcers caused by this infection. This study aims to develop and authenticate a robust and eco-friendly RP-UPLC technique aimed at the concurrent analysis of OMP, AMX, and RFB, following ICH guidelines, Analytical Quality by Design (AQbD), and green analytical chemistry (GAC) principles. The analysis used the Thermo C18 column (100 mm × 2.1 mm, 1.7 µm), ethanol, and formic acid solution (43:57) as mobile phase with a flow rate of 0.2 ml/min at 272 nm. The method was developed based on the ICH Q14 and validated according to ICH Q2(R1) followed by Forced degradation studies under various conditions. The method showed good linearity for OMP, AMX, and RFB, with coefficient of determination (r2) of 0.9995, 0.9993, and 0.9997, respectively. Precision studies indicated low %RSD values, confirming high reproducibility. Forced degradation studies confirmed the stability of the drugs for 30 min in acid, base, and redox reactions, and they were also stable for 6 h at 105 °C in dry conditions. GAPI assessment depicted a green and yellow pictogram, AGREE scored 0.85, BAGI scored 80, and RGB12 Whiteness Assessment Tool scored 97.5%. The developed RP-UPLC-PDA technique is robust and reliable for the concurrent quantification of the triple combination. It aligns with sustainability goals, enhancing the efficiency and environmental sustainability of pharmaceutical analysis, and setting a benchmark for future analytical methods.https://doi.org/10.1186/s13065-024-01337-6RP-UPLCAnalytical quality by designOmeprazoleAmoxicillinRifabutinGreen analytical chemistry
spellingShingle S. P. Ashnah Baffinsha
Vijayageetha Ragupathi
Hemanth Kumar Chanduluru
AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
BMC Chemistry
RP-UPLC
Analytical quality by design
Omeprazole
Amoxicillin
Rifabutin
Green analytical chemistry
title AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
title_full AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
title_fullStr AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
title_full_unstemmed AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
title_short AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
title_sort aqbd enhanced green rp uplc pda methodology for quantification and forced degradation studies for omeprazole amoxicillin and rifabutin
topic RP-UPLC
Analytical quality by design
Omeprazole
Amoxicillin
Rifabutin
Green analytical chemistry
url https://doi.org/10.1186/s13065-024-01337-6
work_keys_str_mv AT spashnahbaffinsha aqbdenhancedgreenrpuplcpdamethodologyforquantificationandforceddegradationstudiesforomeprazoleamoxicillinandrifabutin
AT vijayageetharagupathi aqbdenhancedgreenrpuplcpdamethodologyforquantificationandforceddegradationstudiesforomeprazoleamoxicillinandrifabutin
AT hemanthkumarchanduluru aqbdenhancedgreenrpuplcpdamethodologyforquantificationandforceddegradationstudiesforomeprazoleamoxicillinandrifabutin